Data / Form D filings / PLX PHARMA INC.
PLX PHARMA INC.: Form D filings
PLX PHARMA INC., a pharmaceuticals company in Houston, TX, filed 6 Form D notices with the SEC between 2009 and 2016. The latest, on March 11, 2016, reports $1.3 million sold of a $2 million offering to 27 investors.
Find out what PLX PHARMA INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8285 EL RIO STREET, SUITE 130, Houston, TX, 77054
- Phone
- (713) 842-1249
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1291520
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 11, 2016 | New notice | $2,000,000 | $1,297,000 | $703,000 | 27 | Feb 23, 2016 | sec.gov |
| Jul 8, 2013 | New notice | $9,000,000 | $9,000,000 | $0 | 51 | May 28, 2013 | sec.gov |
| Mar 19, 2013 | New notice | $8,273,297 | $8,273,297 | $0 | 33 | Apr 9, 2012 | sec.gov |
| Oct 5, 2011 | New notice | $7,000,000 | $2,893,965 | $4,106,035 | 22 | Jul 31, 2011 | sec.gov |
| Aug 9, 2010 | New notice | $6,000,000 | $2,000,020 | $3,999,980 | 21 | Jul 22, 2010 | sec.gov |
| Jul 9, 2009 | New notice | $3,106,961 | $3,106,961 | $0 | 26 | Jan 6, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Upendra Marathi | Executive Officer | |
| Kirk Calhoun | Director | |
| Bob Casale | Director | |
| Gary Balkema | Director | |
| Gary Mossman | Executive Officer | |
| Ron Zimmerman | Executive Officer | |
| David Jorden | Executive Officer | |
| John Hadden II | Director | |
| Michael Valentino | Director | |
| Natasha Giordano | Executive Officer, Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Mar 7, 2016 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what PLX PHARMA INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.